Product Details
JYNA EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE#
Emtricitabine; Tenofovir Disoproxil Fumarate200 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Jyna Pharma Ltd
NRN
C4-0479
Status
Active
Composition
ATC Code
J05AR03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
Product Description
"EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS."
Manufacturer Name
Laurus Labs Limited
Manufacturer Country
INDIA
Approval Date
2021-05-07
Expiry Date
2026-05-06